Neurobiology preclinical services

Our In Vivo preclinical services facility offers a diverse set of efficacy – testing capabilities and compound evaluation in the areas of muscular dystrophy and neurodegeneration.

Duchenne's muscular dystrophy (DMD)

Pre-clinical compound efficacy testing in DMD mdx mice.

Neurodegenerative proof of concept studies

Traditional and exploratory studies available to academic and commercial scientists interested in Spinal muscular atrophy (SMA), Amyotrophic lateral sclerosis (ALS), Friedreich’s ataxia, and other models of neurodegenerative diseases.

Related links for Neurobiology